| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |